查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712814

2025年全球移植診斷市場報告

Transplant Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年移植診斷市場規模將強勁成長。到 2029 年，這一數字將成長至 27.5 億美元，複合年成長率為 7.4%。預測期內的成長歸因於以病人為中心的方法、監管適應、活體捐贈移植的增加、個人化移植醫療以及移植手術的成長。預測期內的關鍵趨勢包括教育和宣傳計劃、市場擴大策略、不斷發展的監管指南、免疫抑制療法的最佳化以及生物標記的發展。

預計未來幾年慢性病的增加將推動移植診斷市場的成長。慢性病是需要持續管理和治療的長期疾病，包括糖尿病、心臟病、氣喘和關節炎等疾病。慢性病的增加是由於人口老化、不健康生活方式的增加（例如不良飲食、缺乏運動、吸菸）以及環境污染物暴露增加等因素造成的。移植診斷對於評估器官功能、適用性和潛在的移植需求至關重要。例如，美國衛生組織美國癌症協會發布的一項研究預測，2022年美國將有609,360人死於癌症，新增190萬例癌症病例，相當於每天約有1,670人死亡。因此，慢性病的流行是推動移植診斷市場擴張的主要因素。

預計器官移植數量的增加將對移植診斷市場的成長做出重大貢獻。器官移植是一種外科手術，將一個人（捐贈者）的器官、組織或細胞群移植到另一個人（接受者）體內或同一個體內。移植診斷在器官移植中至關重要，並提供許多益處，包括改善患者預後和改善相容性評估。這些診斷用於移植前捐贈者合格篩檢、識別移植後併發症以及監測抗菌劑的有效性。例如，根據英國政府機構NHS血液和移植中心（NHSBT）2023年7月發布的報告，2022年至2023年間，接受器官移植的患者數量將增加5％，僅心臟捐贈就將增加20％。這意味著總合2,386 名捐贈者進行了 4,532 例移植手術。因此，器官移植數量的增加正在推動移植診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球移植診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球移植診斷市場：成長率分析
  • 全球移植診斷市場表現：規模與成長，2019-2024
  • 全球移植診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球移植診斷總目標市場（TAM）

第6章市場區隔

  • 全球移植診斷市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑和耗材
  • 裝置
  • 軟體和服務
  • 全球移植診斷市場（依移植類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 固態器官
  • 幹細胞
  • 全球移植診斷市場（依器官、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 腎
  • 肝
  • 心
  • 肺
  • 胰臟
  • 全球移植診斷市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 非分子檢測
  • 分子檢測
  • 全球移植診斷市場：按最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院及移植中心
  • 研究室及移植中心
  • 商業服務供應商
  • 全球移植診斷市場試劑與耗材細分市場（按類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • PCR試劑
  • 抗體和抗原
  • 樣本採集套件
  • 控制材料
  • 全球移植診斷市場、儀器細分、類型、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 流式細胞儀
  • PCR儀
  • 序列器
  • 光度計
  • 全球移植診斷市場軟體及服務細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 數據分析軟體
  • 實驗室資訊管理系統（LIMS）
  • 諮詢服務
  • 技術支援和維護服務

第7章 區域和國家分析

  • 全球移植診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球移植診斷市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 移植診斷市場：競爭格局
  • 移植診斷市場：公司簡介
    • F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Illumina Inc.
  • BioMerieus SA
  • Biomerieux SA
  • Grafton Companies
  • Bio-rad Laboratories Inc.
  • Sigma-Aldrich Corporation
  • Qiagen NV
  • Immucor Transplant Diagnostics Inc.
  • Immucor Inc.
  • Luminex Corporation
  • Affymetrix Inc.
  • CareDx Company
  • One Lambda Inc.
  • Eurobio Scientific Group
  • Gendx BV

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年移植診斷市場：提供新機會的國家
  • 2029年移植診斷市場：細分市場將帶來新機會
  • 2029年移植診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33029

Transplant diagnostics encompass tests performed prior to the transplantation of a donor organ to the recipient patient. In the context of organ transplantation and hematopoietic stem cell transplantation, transplantation diagnostics primarily focus on histocompatibility and immunogenetics.

The primary categories within the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostics instruments are specifically designed products aimed at enhancing the speed and quality of transplant diagnostics. Employing non-molecular assay and molecular assay technologies, transplant diagnostics cover various organs such as kidneys, liver, heart, lungs, and pancreas. The transplant types involved are solid organ and stem cells, with end-users including hospitals and transplant centers, research laboratories and transplant centers, as well as commercial service providers.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transplant diagnostics market size has grown steadily in recent years. It will grow from $2.01 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to development of hla typing, growth in organ transplantations, immunosuppressive therapy advancements, introduction of cross-matching techniques, regulatory standardization.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to patient-centric approaches, regulatory adaptations, rise in living donor transplants, personalized transplant medicine, growth in transplant procedures. Major trends in the forecast period include education and awareness programs, market expansion strategies, regulatory guidelines evolution, immunosuppressive therapy optimization, biomarker development.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the transplant diagnostics market in the coming years. Chronic diseases are long-term medical conditions that require ongoing management and treatment, including illnesses such as diabetes, heart disease, asthma, and arthritis. The rise in chronic diseases can be attributed to factors such as an aging population, a higher incidence of unhealthy lifestyles (including poor diet, physical inactivity, and smoking), and increased exposure to environmental pollutants. Transplant diagnostics are essential for assessing organ function, compatibility, and the potential need for transplantation due to the long-term damage these conditions can inflict on vital organs. For instance, research published by the American Cancer Society, a U.S.-based health organization, projected that in 2022, there would be 609,360 cancer deaths and 1.9 million new cancer cases in the U.S., translating to approximately 1,670 fatalities each day. Therefore, the growing prevalence of chronic diseases is a key driver of the transplant diagnostics market's expansion.

The rising number of organ transplants is expected to significantly contribute to the growth of the transplant diagnostics market. Organ transplantation is a surgical procedure that involves removing an organ, tissue, or group of cells from one person (the donor) and transplanting it into another person (the recipient), or relocating it within the same individual. Transplant diagnostics are vital in organ transplantation, offering numerous benefits such as improved patient outcomes and better compatibility assessment. These diagnostics are utilized for pre-transplant donor eligibility screening, identifying post-transplant complications, and monitoring the effectiveness of antimicrobial agents. For example, a report published in July 2023 by NHS Blood and Transplant (NHSBT), a UK-based government agency, indicated a 5% increase in the number of patients receiving organ transplants during the 2022/23 period, with heart donations alone rising by 20%. This amounted to a total of 4,532 transplants from 2,386 donors. Therefore, the increasing number of organ transplants is a key driver of growth in the transplant diagnostics market.

Prominent companies in the transplant diagnostics market are strategically introducing advanced services to enhance their market profitability. Advanced transplant diagnostic services entail the utilization of innovative diagnostic tools and technologies to enhance the precision and efficiency of pre-transplant and post-transplant testing procedures. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, unveiled Quest Advanced Specialized Transplant Services, an extensive array of cutting-edge diagnostics and support services designed to enhance access to laboratory tests for solid organ, human cell, and tissue transplants. This comprehensive offering includes over 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results integrated into the physician's electronic medical record (EMR), and 24/7 support services, including medical consultation to ensure appropriate test selection and result interpretation impacting patient care. The new services expand upon Quest's previous transplant testing offerings with added capabilities, including patient-customized information packets and expedited testing for patients visiting Quest's 2,100 patient service centers, with some test results obtainable within 8-24 hours.

Companies are increasingly adopting Next Generation Sequencing (NGS) for donor-recipient matching tests. NGS technology facilitates the sequencing of an entire human genome, enabling the matching of genes between donors and recipients to determine the suitability for organ transplantation. Virtually all current transplant diagnostic tests and devices leverage NGS technology to inform decisions related to organ transplantation. Castle Biosciences, for instance, introduced the Decision Dx-CMSeq Test, utilizing NGS (Next Generation Sequencing) to identify somatic mutations in genes.

In August 2022, Eurobio Scientific, a biotechnology company based in France, completed the acquisition of GenDx for $134.3 million (€135 million). This strategic move is anticipated to bolster Eurobio's research efforts in the field of transplantation. GenDx is a molecular diagnostics startup headquartered in the Netherlands.

Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

North America was the largest region in the transplant diagnostics market in 2024. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Reagent And Consumables; Instrument; Software And Services
  • 2) By Transplant Type: Solid Organ; Stem Cell
  • 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
  • 4) By Technology: Non Molecular Assay; Molecular Assay
  • 5) By End User: Hospitals And Transplant Centers; Research Laboratories AndTransplant Centers; Commercial Service Providers
  • Subsegments:
  • 1) By Reagent And Consumables: PCR Reagents; Antibodies And Antigens; Sample Collection Kits; Control Materials
  • 2) By Instrument: Flow Cytometers; PCR Machines; Sequencers; Luminometers
  • 3) By Software And Services: Data Analysis Software; Laboratory Information Management Systems (LIMS); Consulting Services; Technical Support And Maintenance Services
  • Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transplant Diagnostics Market Characteristics

3. Transplant Diagnostics Market Trends And Strategies

4. Transplant Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Transplant Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transplant Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transplant Diagnostics Market Growth Rate Analysis
  • 5.4. Global Transplant Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transplant Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transplant Diagnostics Total Addressable Market (TAM)

6. Transplant Diagnostics Market Segmentation

  • 6.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagent And Consumables
  • Instrument
  • Software And Services
  • 6.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Organ
  • Stem Cell
  • 6.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • 6.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non Molecular Assay
  • Molecular Assay
  • 6.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Transplant Centers
  • Research Laboratories And Transplant Centers
  • Commercial Service Providers
  • 6.6. Global Transplant Diagnostics Market, Sub-Segmentation Of Reagent And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • Antibodies And Antigens
  • Sample Collection Kits
  • Control Materials
  • 6.7. Global Transplant Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flow Cytometers
  • PCR Machines
  • Sequencers
  • Luminometers
  • 6.8. Global Transplant Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Laboratory Information Management Systems (LIMS)
  • Consulting Services
  • Technical Support And Maintenance Services

7. Transplant Diagnostics Market Regional And Country Analysis

  • 7.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transplant Diagnostics Market

  • 8.1. Asia-Pacific Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transplant Diagnostics Market

  • 9.1. China Transplant Diagnostics Market Overview
  • 9.2. China Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transplant Diagnostics Market

  • 10.1. India Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transplant Diagnostics Market

  • 11.1. Japan Transplant Diagnostics Market Overview
  • 11.2. Japan Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transplant Diagnostics Market

  • 12.1. Australia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transplant Diagnostics Market

  • 13.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transplant Diagnostics Market

  • 14.1. South Korea Transplant Diagnostics Market Overview
  • 14.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transplant Diagnostics Market

  • 15.1. Western Europe Transplant Diagnostics Market Overview
  • 15.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transplant Diagnostics Market

  • 16.1. UK Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transplant Diagnostics Market

  • 17.1. Germany Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transplant Diagnostics Market

  • 18.1. France Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transplant Diagnostics Market

  • 19.1. Italy Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transplant Diagnostics Market

  • 20.1. Spain Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transplant Diagnostics Market

  • 21.1. Eastern Europe Transplant Diagnostics Market Overview
  • 21.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transplant Diagnostics Market

  • 22.1. Russia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transplant Diagnostics Market

  • 23.1. North America Transplant Diagnostics Market Overview
  • 23.2. North America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transplant Diagnostics Market

  • 24.1. USA Transplant Diagnostics Market Overview
  • 24.2. USA Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transplant Diagnostics Market

  • 25.1. Canada Transplant Diagnostics Market Overview
  • 25.2. Canada Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transplant Diagnostics Market

  • 26.1. South America Transplant Diagnostics Market Overview
  • 26.2. South America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transplant Diagnostics Market

  • 27.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transplant Diagnostics Market

  • 28.1. Middle East Transplant Diagnostics Market Overview
  • 28.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transplant Diagnostics Market

  • 29.1. Africa Transplant Diagnostics Market Overview
  • 29.2. Africa Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transplant Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Transplant Diagnostics Market Competitive Landscape
  • 30.2. Transplant Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transplant Diagnostics Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. BioMerieus S.A
  • 31.3. Biomerieux SA
  • 31.4. Grafton Companies
  • 31.5. Bio-rad Laboratories Inc.
  • 31.6. Sigma-Aldrich Corporation
  • 31.7. Qiagen N.V.
  • 31.8. Immucor Transplant Diagnostics Inc.
  • 31.9. Immucor Inc.
  • 31.10. Luminex Corporation
  • 31.11. Affymetrix Inc.
  • 31.12. CareDx Company
  • 31.13. One Lambda Inc.
  • 31.14. Eurobio Scientific Group
  • 31.15. Gendx BV

32. Global Transplant Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transplant Diagnostics Market

34. Recent Developments In The Transplant Diagnostics Market

35. Transplant Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Transplant Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transplant Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transplant Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer